Cyteir Therapeutics, Inc.

3.07 USD
-0.03 (-0.97%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Cyteir Therapeutics, Inc. stock is down -1.29% since 30 days ago. The next earnings date is Mar 21, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 52% of the previous 30 February’s closed higher than January.

About Cyteir Therapeutics, Inc.

Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851 is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies. The company was incorporated in 2012 and is based in Lexington, Massachusetts.